SC 13D/A | 2020-05-22 | AI Gamida Holdings LLC | Gamida Cell Ltd. | 3,750,000 | 7.9% | EDGAR |
SC 13G/A | 2020-02-14 | Gabriel Capital Management Ltd. | Gamida Cell Ltd. | 2,158,093 | 6.3% | EDGAR |
SC 13G | 2020-02-14 | Israel HealthCare Ventures 2 L.P. | Gamida Cell Ltd. | 1,915,508 | 5.7% | EDGAR |
SC 13G | 2020-02-07 | FMR LLC | Gamida Cell Ltd. | 2,878,270 | 8.7% | EDGAR |
SC 13D/A | 2019-07-03 | AI Gamida Holdings LLC | Gamida Cell Ltd. | 3,750,000 | 11.5% | EDGAR |
SC 13G | 2019-04-09 | Smartmix Ltd | Gamida Cell Ltd. | 2,857,331 | 11.3% | EDGAR |
SC 13G | 2019-02-14 | Gabriel Capital Management Ltd. | Gamida Cell Ltd. | 2,682,461 | 10.5% | EDGAR |
SC 13G | 2019-02-14 | Israel HealthCare Ventures 2 L.P. | Gamida Cell Ltd. | 1,915,508 | 7.9% | EDGAR |
SC 13G | 2019-02-14 | ELBIT IMAGING LTD | Gamida Cell Ltd. | 2,685,590 | 10.8% | EDGAR |
SC 13D | 2018-11-09 | AI Gamida Holdings LLC | Gamida Cell Ltd. | 3,750,000 | - | EDGAR |
SC 13D | 2018-11-08 | NOVARTIS PHARMA AG | Gamida Cell Ltd. | 5,192,135 | 20.7% | EDGAR |